Product analysis
Male Response supplies nutrients that support normal immune and hair functions when intake is low. A stimulant in the formula may increase anxiety or heart rate, which can work against comfortable concentration.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality38
Vitamin B6, vitamin B5 and copper forms are identified and have generally favorable quality findings. Many plant preparations are unspecified, and the selenium mixture has unknown proportions that limit a precise quality comparison.
Ingredient Transparency60
Ingredient amounts are disclosed, helping compare the serving. Most plant preparations and the selenium source proportions remain unspecified.
Value For Money36
Many assessable ingredients compare less favorably on cost. Vitamin B6, eleuthero and ginger offer moderate value, while several other ingredient comparisons remain uncertain.
Customer Satisfaction65
Customer feedback is generally positive, with some room for dissatisfaction. A moderate number of ratings gives useful feedback without establishing effectiveness.
Product Focus31
The formula combines many nutrients and plants across several goals, making it less focused. Benefits depend partly on nutrient status and preparation, while a stimulant may work against calm concentration.
- Format
Tablet - Container
- 90 Tablet(s)
- Per serving
- $0.79
- Customer rating
- 4.2 · 337 ratings
Goals
No linked studies yet.
No linked studies yet.
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 10 Calorie(s) | |
Total Carbohydrates | 1 Gram(s) | |
Vitamin E (Vitamin E Succinate) | 100 IU | |
Vitamin B6 (Pyridoxine Hydrochloride) | 25 mg | |
Pantothenic Acid (Calcium D-Pantothenate) | 50 mg | |
Zinc (OptiZinc) | 15 mg | |
Selenium (L-Selenomethionine, Sodium Selenite) | 150 mcg | |
Copper (Copper Sebacate) | 1 mg | |
Sodium | 10 mg | |
Tribulus fruit extract | 500 mg | |
Maca | 300 mg | |
Epimedium aerial parts extract (Flavonoids) | 300 mg | |
L-Arginine (L-Arginine Pyroglutamate) | 300 mg | |
Ashwagandha Root Extract | 250 mg | |
Yohimbe Bark Extract | 225 mg | |
Asian Ginseng root extract | 210 mg | |
Oat tops extract | 200 mg | |
Damiana | 200 mg | |
Saw Palmetto | 200 mg | |
Sarsaparilla | 200 mg | |
Eleuthero Root Extract | 200 mg | |
Ginkgo leaf extract | 60 mg | |
Stinging Nettle Root Extract | 60 mg | |
Ginger | 60 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability79
Copper Form Bioavailability
Elemental Copper Labeling Clarity
Dose, Safety & Label Transparency86
Copper Dosage Safety & Efficacy
Zinc-to-Copper Balance
Value30
Price Per Serving Efficiency
How this ingredient is rated
Ingredient Form & Label Quality100
Vitamin B6 Form Identification
Clean Label and Excipient Purity
Dose, Safety & Label Transparency60
Vitamin B6 Dose & Safety Policy
Label Transparency
Value54
Vitamin B6 Price Efficiency
How this ingredient is rated
Active Ingredient Quality & Bioavailability90
Vitamin B5 Chemical Form
Dose, Safety & Label Transparency76
Dosage Potency and Efficacy
Label Transparency & Source Clarity
Value20
Price per 500mg Vitamin B5
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study.
- Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.
- A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study.
- Efficacy and safety of ashwagandha root extract in children and adolescents with mild attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial.
- Efficacy of Withania somnifera supplementation on adult's cognition and mood.
- No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia.
- Associations between dietary B vitamin intakes and cognitive function among elderly individuals: An observational study.
- Lower Plasma Vitamin B-6 is Associated with 2-Year Cognitive Decline in the Boston Puerto Rican Health Study.
- Lower water-soluble vitamins and higher homocysteine are associated with neurodegenerative diseases.
- Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction.
- Efficacy of Zinc Supplement in Minimal hepatic Encephalopathy: A prospective, Randomized Controlled Study (Zinc-MHE Trial).
- Effects of zinc supplementation on parent and teacher behaviour rating scores in low socioeconomic level Turkish primary school children.
- L-shaped association between dietary zinc intake and cognitive decline in Chinese older people.
- The efficacy of zinc augmentation in children with attention deficit hyperactivity disorder under treatment with methylphenidate: A randomized controlled trial.